516-35-8
基本信息
牛磺鵝去氧膽酸
?;蛆Z去氧膽酸鈉鹽
純天然?;蛆Z去氧膽酸
牛磺鵝去氧膽酸標(biāo)準(zhǔn)品
?;蛆Z去氧膽酸對照品
?;蛆Z脫氧膽酸(TCDCA)
?;蛆Z去氧膽酸?, 99.5%
?;蛆Z脫氧膽酸(?;蛆Z去氧膽酸)
【純天然?;蛆Z去氧膽酸】醫(yī)藥含量98%白色粉末
C05465
Chenyltaurine
12-Deoxycholyltaurine
Taurochenodeoxycholic
12-Desoxycholyltaurine
Chenodeoxycholyltaurine
aurochenodeoxycholicaci
Chenodeoxycholoyltaurine
Taurochenodeoxycholic acid
物理化學(xué)性質(zhì)
報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
2024/11/08 | HY-N2027 | ?;蛆Z去氧膽酸 Taurochenodeoxycholic acid | 516-35-8 | 25 mg | 400元 |
2024/11/08 | HY-N2027 | ?;蛆Z去氧膽酸 Taurochenodeoxycholic acid | 516-35-8 | 10mM * 1mLin DMSO | 440元 |
2024/11/08 | HY-N2027 | ?;蛆Z去氧膽酸 Taurochenodeoxycholic acid | 516-35-8 | 50mg | 600元 |
常見問題列表
Human Endogenous Metabolite
|
Taurochenodeoxycholic acid (12-Deoxycholyltaurine) dramatically improves the apoptosis rate of NR8383 cells in a concentration-dependent manner. In the meantime, Taurochenodeoxycholic acid significantly augments PKC mRNA levels, activities and increases JNK, caspase-3 and caspase-8 mRNA expression levels, activities.
Taurochenodeoxycholic acid (12-Deoxycholyltaurine; 0.05, 0.1g/kg) decreases the pulmonary coefficient in the model mice and reduces the pathological damages on their lungs; it can decrease the expression levels of TNF-α and TIMP-2 in pulmonary tissues in the pulmonary fibrosis mice and has no significant effects on MMP2.
Taurochenodeoxycholic acid significantly normalizes the clinical inflammatory parameters, prevented indomethacin-induced increases in the biliary contents of secondary bile acids and hydrophobicity index, and tended to attenuate the intestinal inflammation.
Taurochenodeoxycholic acid significantly suppresses paw swelling and polyarthritis index, increases the loss body weight and index of thymus and spleen, and amends radiologic changes in AA rats. The overproduction and mRNA expression of TNF-α, IL-1β and IL-6 are remarkably suppressed in serum and synovium tissue of all TCDCA-treated rats.